A detailed history of Guardian Wealth Management, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Guardian Wealth Management, Inc. holds 1,050 shares of NVO stock, worth $115,206. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,050
Previous 1,050 -0.0%
Holding current value
$115,206
Previous $134,000 11.19%
% of portfolio
0.12%
Previous 0.11%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 31, 2023

BUY
$90.94 - $199.54 $47,743 - $104,758
525 Added 100.0%
1,050 $95,000
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $11,910 - $14,616
-125 Reduced 19.23%
525 $52,000
Q2 2022

Aug 15, 2022

SELL
$103.24 - $121.81 $8,775 - $10,353
-85 Reduced 11.56%
650 $72,000
Q4 2021

Feb 15, 2022

BUY
$95.88 - $117.08 $70,471 - $86,053
735 New
735 $82,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $248B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Guardian Wealth Management, Inc. Portfolio

Follow Guardian Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Guardian Wealth Management, Inc. with notifications on news.